Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PRPH

ProPhase Labs, Inc.

CIK 0000868278 · OTC

OTCHealth CarePharmaceutical Preparations
$0.02
↓ 0.00 (-8.86%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$385.14K
P/E Ratio
-0.02
EPS
-1.74
Dividend Yield
Not covered
52W Position
0%
Beta
0.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.12
P/S
0.10
EV/Revenue
0.09
ROE
722.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 0%
$0.02$1.15

Latest Financials

2025-12-31 FY
Revenue
$4.34M
Net Income
-$14.74M
Total Assets
$59.87M
Free Cash Flow
–

Recent news